​

For patients receiving Pfizer 6 months to 4 years old:

We do NOT have these vaccines in stock. This website will be updated when/if they become available. 

​

For patients receiving Pfizer 5 to 11 years old:

We do NOT have these vaccines in stock. This website will be updated when/if they become available. 

​

Single Dose of Pfizer-BioNTech COVID-19 2024-25 vaccines for ages 5-11 years recommended regardless of previous vaccination status, at least 8 weeks after receipt of the most recent dose of any COVID vaccine. 

​

Minors must be accompanied by a guardian to receive vaccination. 

​

Additional doses may be available for those who are moderate to severely immune compromised. More info about that is available through the CDC's website here: 

​

https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html

​

​

​

​

For patients receiving Pfizer 12 years or older:

Single Dose of Comirnaty (Pfizer-BioNTech) COVID-19 2024-25 vaccine for ages 12 years or older recommended, regardless of previous vaccination status, at least 8 weeks after receipt of the most recent dose of any COVID vaccine. 

​

Minors must be accompanied by a guardian to receive vaccination.

​

Additional doses may be available for those who are moderate to severely immune compromised. More info about that is available through the CDC's website here: 

​

https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html

​​

 

 

​

​​​​

For patients receiving Moderna ages 6 months to 11 years old:

Ages 6 Months to 4 Years, Unvaccinated: Two Doses of Moderna COVID-19 Vaccine, 4-8 weeks apart 

Ages 6 Months to 4 Years, Previously vaccinated with ONE dose of Moderna: One Dose 4-8 weeks after last dose

Ages 6 Months to 4 Years, two or more doses of any previous Moderna vaccines, but not Moderna 2024-25 version: One Dose at least 8 weeks after last dose 

​

Ages 5 to 11 Years, Unvaccinated: One Dose of Moderna COVID-19 Vaccine 

 

Ages 5 to 11 Years, Previously vaccinated with one or more doses of Moderna: One Dose at least 8 weeks after last dose

​​

Minors must be accompanied by a guardian to receive vaccination. 

​

​Additional doses may be available for those who are moderate to severely immune compromised. Find out about that here on the CDC's website: 
https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html ​

​

​

​

​

​

For patients receiving Moderna ages 12 years or older:

Single Dose of Spikevax (Moderna) COVID-19 2024-25 vaccine for ages 12 years or older recommended, regardless of previous vaccination status, at least 8 weeks after receipt of the most recent dose of any COVID vaccine. ​

​

Minors must be accompanied by a guardian to receive vaccination. 

​

Additional doses may be available for those who are moderate to severely immune compromised. More info about that is available through the CDC's website here: 

​

https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html

​​

​​​​​​​​

​

​

​

For patients receiving Novavax ages 12 years or older:

For those previously vaccinated with any number of COVID-19 vaccines: Single Dose of Novavax COVID-19 2024-25 vaccine for ages 12 years or older recommended at least 8 weeks after receipt of the most recent dose of any COVID vaccine. ​

​

For those previously unvaccinated: Two Dose series of Novavax COVID-19 2024-25 vaccine for ages 12 years or older recommended, with 3 to 8 weeks between the two doses. 

​​​​​

Minors must be accompanied by a guardian to receive vaccination. 

​

Additional doses may be available for those who are moderate to severely immune compromised. More info about that is available through the CDC's website here: 

​​

https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html

​

​

​